Tandem Diabetes Acquires Swiss Based Insulin Patch Pump Developer
-
Tandem Diabetes Care Inc (NASDAQ: TNDM) has agreed to acquire AMF Medical SAPrivately held Swiss developer of the Sigi Patch Pump.
-
It is an ergonomic, rechargeable and comfortable patch pump.
-
Tandem’s Type 1 and Type 2 market opportunities will be further expanded with this acquisition.
-
AMF Medical will be purchased by Tandem Diabetes Care as per the following financial terms:
-
In Q3 2022, a previous strategic investment in the amount of CHF 8.2 million was made.
-
At closing, a cash payment of CHF62.4 million will be made.
-
Additional contingent earnout payments up to CHF 129.5 million are available upon reaching certain milestones.
-
The transaction is expected closing in January 2023.
-
Price Action TNDM shares are now at $42.16, down 3.40% since Tuesday’s last check.
More information from Benzinga
Join now to get real-time alerts for your stocks Benzinga Pro Free! Try the tool that will help you invest smarter, faster, and better.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.